Perepelyuk
Mykola Mykolayovych

Priority fields of work

You can contact Mykola Perepelyuk both during preparation for surgery and for the treatment of chronic diseases:

• cardiovascular diseases (arterial hypertension, ischemic heart disease, myocarditis, heart defects, heart rhythm disorders, heart failure of any origin) including – in combination with diabetes mellitus, obesity, anemia
• chronic hepatitis and cirrhosis of the liver, metabolic-associated fatty liver disease, intestinal dysbiosis, Crohn’s disease and nonspecific ulcerative colitis
• chronic fatigue

Education

1994 – graduated from Odessa Medical University named after M.I. Pirogov

Internships, conferences, seminars of recent years:

• Participation in the author’s course «Mastery of Public Speaking», Kyiv, 06/13/2018.
• Internship within the framework of the Educational Program for Doctors, organized by the Association of French-Ukrainian Cooperation in Medicine and Pharmacy (ASFUDS) with the assistance of the World Federation of Ukrainian Medical Societies: France, July 27 – August 6, 2018 (certificate No. 003089), as well as October 13 – 20, 2019 (certificate No. 003759).
• “Modern teaching technologies in higher medical educational institutions based on psychological, pedagogical and moral and ethical aspects”, Ivano-Frankivsk Academy of Ivan Zolotousty, 22.05.2023 – 04.06.2023

Membership in professional communities

Since 2018, member of the Association of Preventive and Anti-Aging Medicine

Scientific and scientific and educational work

• On 10.31.2000, in the specialized Academic Council of the Research Institute of Medical Rehabilitation and Balneology of the Ministry of Health of Ukraine, he defended his dissertation for the degree of Candidate of Medical Sciences in the specialty “Balneology and Physiotherapy”. The title of the dissertation is “Comparative effectiveness of preformed physical factors in the complex rehabilitation treatment of patients with angina pectoris”. Diploma DK No. 010295.
• In 2003-2008 – was engaged in experimental research in the field of regeneration technologies at the Institute of Molecular Genetics and Therapy at Odessa State Medical University.
• During 2008-2018, as the principal investigator, he participated in 3 multicenter randomized placebo-controlled studies on the efficacy and safety of oral anticoagulants in seriously ill patients.
• Prizewinner of the National Competition “For the Best Digital Solution in Cardiology” within the framework of the XXI National Congress of Cardiologists of Ukraine 2020.
• Lecturer of the Association of Outpatient Medicine
• Associate Professor of the Department of Internal Medicine No. 2 with postgraduate education at ONMedU
• Author or co-author of 92 published works and 8 patents

Scientific works on regenerative medicine (co-authored):

• Ethical and moral problems of stem cell transplantation and their derivatives, 2004
• The use of cytokines, stem and progenitor cells in myocardial regeneration (clinical and experimental parallels), 2005
• The use of granulocyte colony-stimulating factor in the regeneration of dystrophic myocardium, 2005
• Experimental justification of the use of cell technologies in myocardial regeneration, 2005
• Modern biotechnologies in regenerative medicine (review) literature and own research), 2007
• Regenerative medicine: state in Ukraine, 2007
• Possibilities of using cytokines in regenerative medicine, 2007
• Use of erythropoietin in heart failure: experimental and clinical study, 2008
• Use of erythropoietin in cardiovascular diseases, 2008
• Possibilities of using erythropoietin for correction of liver fibrosis at different stages of its formation, 2008
• Use of recombinant erythropoietin in complex therapy of chronic heart failure (CHF), 2008
• Use of granulocyte colony-stimulating factor (G-CSF) in correction of toxic hepatitis, 2008
• Protective efficacy of Gr-CSF under the conditions of administration (on the example of adriablastine-induced cardiomyopathy), 2008
• Experimental study of the efficacy therapy of toxic hepatitis with platelet-rich plasma, 2014
• A case of regression of liver fibrosis in a young patient, 2015
• Pathogenesis of liver fibrosis and possibilities of its correction, 2016
• Study of biological effects of platelet-rich plasma in an experiment, 2017
• Cirrhosis of the liver – when to change the antifibrotic paradigm to the angiogenic one?, 2017
• Transformation of chronic hepatitis into cirrhosis of the liver – where is the “point of no return”?, 2018
• Clinical significance of thrombocytopathy in cirrhosis of the liver, 2018
• Platelet-rich plasma as a chance for recovery for a patient with cirrhosis of the liver, 2019